The summarized graph for the values of the coefficients of significant linear trends. by Ekaterina Ivanova (230383)

The linearly decreasing convergence factor a. by Junhao Wei (6816803)

Brain regions with significantly decreased activations for the Raven task are shown in blue. by Morteza Fattahi (15892028)

Statistically significant linear increase in use of antidepressants during the observed time period. by Jelena Filimonovic (22305307)

Comparison of cell cytotoxicity effect. by Alireza Latifi (14593561)

Subjects:

SHG-44 did not lead to a significant production of ROS release. by Denis Mustafov (19137870)

Statistically significant linear increase in use of antidementia medications and antipsychotics during the observed time period. by Jelena Filimonovic (22305307)

Statistically significant linear decrease in use of antidepressants, antipsychotics, psychostimulants and nootropic drugs, anxiolytics, sedatives and hypnotics during the observed time period. by Jelena Filimonovic (22305307)

Significant interactions from mixed linear models of ECM colonization (Table 1). by Laura García de Jalón (8939456)

Join-point regression analysis of the statistically significant linear increase in use of antidepressants during the observed time period. by Jelena Filimonovic (22305307)

In vitro drug release profile of MF and miltefosine-loaded chitosan nanoparticles in phosphate buffer (pH 7.2). by Alireza Latifi (14593561)

Subjects:

Fitted estimates and significance levels of linear mixed models for seedling germination, survival and growth. by Laura García de Jalón (8939456)

Join-point regression analysis of the statistically significant linear increase in use of antidementia and antipsychotics during the observed time period. by Jelena Filimonovic (22305307)

Linear regression. by Myriam Aïche (22290591)

Effects of MF, MF-CS-NPs, and CS-NPs on <i>Vero</i> cell viability after 24 and 48 hours of drug exposure. by Alireza Latifi (14593561)

Subjects:

Statistically significant linear increase in use of psychostimulants and nootropic drugs, anxiolytics, sedatives and hypnotics, gabapentinoids during the observed time period. by Jelena Filimonovic (22305307)

Data_Sheet_1_Serum Anti-Müllerian Hormone Is Significantly Altered by Downregulation With Daily Gonadotropin-Releasing Hormone Agonist: A Prospective Cohort Study.docx by Panagiotis Drakopoulos (5444162)

“…A linear, mixed-effect model demonstrated that GnRH agonist treatment for 7 and 14 days had a highly significant effect on serum AMH concentration after adjustment for confounding factors (age, body mass index, baseline antral follicle count, and visit). …”

Boxplots for total calcium released to the citric acid, according to the solutions. by Thiago Saads Carvalho (14129325)

Subjects:

Linear contact model. by Qingwen Li (1510687)

Prevalence of significantly comorbid psychiatric symptoms and diagnoses in those reporting anhedonia at baseline. by Yi Zhou (2723)

Subjects: